Samalin Investment Counsel LLC Lowers Stock Position in Healthpeak Properties, Inc. (NYSE:DOC)

Samalin Investment Counsel LLC lessened its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 5.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 35,070 shares of the real estate investment trust’s stock after selling 2,204 shares during the quarter. Samalin Investment Counsel LLC’s holdings in Healthpeak Properties were worth $711,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in the business. State Street Corp purchased a new stake in Healthpeak Properties in the 3rd quarter valued at approximately $1,093,576,000. JPMorgan Chase & Co. boosted its stake in shares of Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after acquiring an additional 4,056,931 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of Healthpeak Properties by 2,113.5% during the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock worth $367,575,000 after acquiring an additional 17,314,572 shares in the last quarter. Geode Capital Management LLC purchased a new stake in shares of Healthpeak Properties during the 3rd quarter worth approximately $403,898,000. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Healthpeak Properties by 0.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 10,153,450 shares of the real estate investment trust’s stock worth $205,810,000 after acquiring an additional 53,392 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Trading Down 1.6 %

Shares of DOC opened at $20.02 on Friday. The stock has a fifty day moving average of $20.24 and a two-hundred day moving average of $21.17. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. The company has a market capitalization of $14.00 billion, a PE ratio of 57.19, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a fifty-two week low of $17.45 and a fifty-two week high of $23.26.

Healthpeak Properties Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were issued a $0.305 dividend. The ex-dividend date of this dividend was Friday, February 14th. This is an increase from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 6.10%. Healthpeak Properties’s payout ratio is 348.57%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Wedbush decreased their price target on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, February 14th. StockNews.com raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Saturday. Robert W. Baird decreased their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Tuesday, February 11th. Mizuho decreased their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Thursday, December 5th. Finally, Wells Fargo & Company decreased their price target on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 10th. Four investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $23.92.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.